A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors
Trial details
- Registry ID
- NCT05551117
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as MGC018
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsNCT05551117 | MacroGenics | Phase 2 | Terminated | 2024-07-04Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |